Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis
CzechiaStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
BelgiumStudy on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults
BulgariaStudy of Baricitinib for Children and Adolescents with Moderate-to-Severe Atopic Dermatitis
AustriaStudy on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy
BulgariaStudy of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus
BulgariaStudy on the Effects of JNJ-81241459 for Patients with Moderate to Severe Psoriasis
FranceStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
FranceStudy on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis
HungaryStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
BulgariaStudy on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis
BulgariaThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
